Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Viatris Earnings Preview: What to Expect

Viatris Inc. (VTRS), valued at a market cap of $14.6 billion, is a global pharmaceutical and healthcare company formed in November 2020. Headquartered in Canonsburg, Pennsylvania, it develops, manufactures and distributes a broad portfolio of generic, branded, complex generic and biosimilar medicines across more than 165 countries and territories, supplying high-quality medicines to roughly 1 billion patients globally each year. 

The global healthcare giant is expected to announce its fiscal 2025 fourth-quarter earnings soon. Ahead of the event, analysts expect VTRS to report a profit of $0.53 per share on a diluted basis, down 1.9% from $0.54 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.